Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open‐label, crossover study
暂无分享,去创建一个
F. Montorsi | G. Jackson | I. Eardley | V. Mirone | G. Vail | K. Loughney | A. Beardsworth | M. Chan
[1] B. Meibohm,et al. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy , 2007, International Journal of Impotence Research.
[2] G. Hackett,et al. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study. , 2006, The journal of sexual medicine.
[3] S. Kimmel,et al. ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Can Atorvastatin Improve the Response to Sildenafil in Men with Erectile Dysfunction Not Initially Responsive to Sildenafil? Hypothesis and Pilot Trial Results , 2006 .
[4] G. Jackson,et al. Erectile dysfunction and statin treatment in high cardiovascular risk patients , 2006, International journal of clinical practice.
[5] F. Montorsi,et al. An open‐label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy , 2005, BJU international.
[6] R. Rosen,et al. The Psychological and Interpersonal Relationship Scales: Assessing Psychological and Relationship Outcomes Associated with Erectile Dysfunction and Its Treatment , 2004, Archives of sexual behavior.
[7] I. Goldstein,et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial , 2001, International Journal of Impotence Research.
[8] H. Padma-nathan,et al. On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunction , 2001, International Journal of Impotence Research.
[9] I. Goldstein,et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. , 1998, The New England journal of medicine.
[10] I. Osterloh,et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. , 1999, Urology.
[11] T F Lue,et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. , 1998, The New England journal of medicine.
[12] I. Osterloh,et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. , 1997, Urology.